- Home
- SBFG vs LFCR Comparison
SBFG vs LFCR Comparison
Compare SBFG & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBFG | LFCR |
|---|---|---|
| Founded | 1983 | 1986 |
| Country | United States | United States |
| Employees | 254 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.4M | 143.9M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SBFG | LFCR |
|---|---|---|
| Price | $21.40 | $4.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 5.1K | ★ 180.7K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | ★ 27.33 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | $31.25 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $17.10 | $3.63 |
| 52 Week High | $23.93 | $8.98 |
Technical Indicators
Market Signals| Indicator | SBFG | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 36.40 |
| Support Level | $20.90 | $3.63 |
| Resistance Level | $22.70 | $5.45 |
| Average True Range (ATR) | 0.62 | 0.28 |
| MACD | -0.10 | -0.06 |
| Stochastic Oscillator | 26.61 | 13.94 |
Price Performance
Historical ComparisonAbout SBFG SB Financial Group Inc.
SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in a single segment, which is Banking.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.